029HO18708 KENOBI

Print/PDF
Registration Name DE-SU 14222 KENOBI-ET
Registration Number HO840003141559616
Primary NAAB Code 029HO18708
Secondary Code(s) 629HO18708
Status Inactive
Controller Name ABS Global (29)
Date of Birth 5/22/2017
aAa 432
DMS -
GFI 13.1%
Genetic Codes * TV TL TY TC TD TR
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire S-S-I MONTROSS JEDI-ET
MGS WESTENRADE ALTASPRING-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ 467, 93% R CM$ 496
NM Percentile 46% FM$ 402
GTPI 2843 GM$ 417
PRODUCTION TRAITS
6584 Dtrs 1202 herds 27 % US 99% R
Milk 568 Fat, % 28 , +0.02%
SCS 2.82, 99% R Protein, % 35 , +0.06%
Feed Saved 105 , 64% R Milking Speed 6.78 , 94% R
Health & Fertility
Productive Life 3.1      99% R Mastitis 2.0      97% R
Heifer Livability 0.4       90% R Metritis 1.8      95% R
Livability 2.0      95% R D. Abom 0.2      95% R
DPR -0.8      99% R Ketosis 1.7      92% R
FSC -2.0      99% R R. Placenta 0.7      95% R
HCR -3.3      97% R Milk Fever 0.1      89% R
CCR -0.7      99% R
SCR -        -
DIA 0.5      64% R
RSP -2.9      87% R
Calving Traits
Sire CE 0.9      98% R 5174 Obs
Daughter CE 1.2      98% R 735 Obs, 3318 Dtrs
Sire SB 2.9      97% R 6112 Obs
Daughter SB 3.2      97% R 688 Obs, Dtrs
Gestation Length -0.8      99% R 137 Obs, 2366 Dtrs
Early First Calving -1.0      98% R 142 Obs, 1527 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
2685 Dtrs 594 herds 98% R
PTA Type 0.18 UDC 0.40
HCC 0.32 BWC 0.01
FLC -1.46
Linear Traits
Stature -0.63
Short
Strength -0.07
Weak
Body Depth -0.22
Shallow
Dairy Form -0.60
Closed
Rump Angle 0.19
Sloped
Thurl Width -0.33
Sloped
Rear Legs-Side View -0.33
Narrow
Rear Legs-Rear View -2.18
H.-in
Foot Angle -0.50
Low
Feet & Legs Score -1.27
Low
F.U. Attachment -1.71
Straight
Rear Udder Height 0.28
High
Rear Udder Width -0.36
Narrow
Udder Cleft 0.05
Strong
Udder Depth -2.18
H.-in
Front Teat Placement -0.21
Wide
Rear Teat Placement -0.26
Wide
Teat Length 0.77
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO